** Shares of healthcare products developer BLIS Technologies
Ltd BLT.NZ rise as much as 7.4% to NZ$0.029
** Co hikes full-year revenue estimates to around NZ$10.1
mln ($6.36 mln), compared with earlier guidance of NZ$9.5
mln-NZ$9.8 mln, on account of improved company performance
** Co further expects EBITDA deficit of between NZ$0.6 mln
and NZ$0.7 mln, compared with earlier range of NZ$1.0 mln to
NZ$1.2 mln
** More than 527,000 shares change hands, compared with the
30-day average volume of about 238,000 shares
** Stock has risen 8% this year, as of last close
($1 = 1.5878 New Zealand dollars)
(Reporting by Jaskiran Singh in Bengaluru)
((Jaskiran.Singh@thomsonreuters.com;))